Why the study?
Anthracycline-induced cardiotoxicity limits cancer therapy, and dietary nitrate supplementation has shown preclinical cardioprotection in doxorubicin-induced injury.
Does dietary nitrate and nitrite supplementation reduce doxorubicin-induced cardiac fibrosis and oxidative damage in tumor-bearing mice?
Does dietary nitrate and nitrite supplementation reduce doxorubicin-induced cardiac fibrosis and oxidative damage in tumor-bearing mice?
Dietary nitrate and nitrite supplementation mitigates doxorubicin-induced cardiac fibrosis and oxidative stress in a preclinical breast cancer model without compromising chemotherapeutic efficacy.
Hypothesis-generating for NOx cardioprotection during doxorubicin; human trials required before any clinical consideration.
Anthracycline-induced cardiotoxicity remains a major limitation in cancer therapy, affecting long-term cardiovascular health in survivors. Dietary nitrate supplementation has shown cardioprotective effects in preclinical models of doxorubicin (Dox)-induced and ischemia-reperfusion injury. In this study, we evaluated the protective effects of nitrate and nitrite (NOx) supplementation in a syngeneic, tumor-bearing mouse model undergoing Dox chemotherapy (N=5 per group). NOx supplementation significantly reduced cardiac fibrosis and levels of 4-hydroxynonenal-modified proteins, a marker of oxidative stress. Tumor sizes varied, but most regressed by the final Dox dose. Importantly, NOx did not compromise the anti-tumor efficacy of Dox nor did it promote pulmonary metastasis. These findings support the potential clinical use of dietary nitrate and nitrite as adjuncts to Dox treatment to mitigate cardiotoxicity without impairing anti-cancer outcomes.
No takes yet. Share an insight, caveat, or question.
Yammani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: